Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
![PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f33163534f9a85acc25579932597eab0cf9e71ff/7-Figure1-1.png "PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar")
PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar
Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Kaplan-Meier Estimates of Disease-free Survival and Overall Survival in... | Download Scientific Diagram
Kaplan-Meier survival curves for disease-free survival and overall... | Download Scientific Diagram
Disease Free Survival - an overview | ScienceDirect Topics
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials | Journal for ImmunoTherapy of Cancer
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma | PLOS ONE
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer | NEJM
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Disease Free Survival - an overview | ScienceDirect Topics
